Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials (Q35148792)

6 August 2017

0 references

Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials (English)

1 reference

6 August 2017

1 reference

Yanqiong Liu

1

1 reference

6 August 2017

Aiping Qin

2

1 reference

6 August 2017

Taijie Li

3

1 reference

6 August 2017

Xue Qin

4

1 reference

6 August 2017

Shan Li

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

13 April 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

133

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

647-655

1 reference

Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

7 January 2021

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Cancer risk among statin users: a population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and female reproductive organ cancer risk in a large population-based setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Incidence of cancer and statin usage--record linkage study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and cancer risk in the General Practice Research Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and the risk of 10 cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

The effect of statins on risk and survival of gynecological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Common cancer risk and statins: a population-based case-control study in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statins and cancer: A systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Quantitative methods in the review of epidemiologic literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Meta-analysis in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Measuring inconsistency in meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Quantifying heterogeneity in a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Bias in meta-analysis detected by a simple, graphical test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Operating characteristics of a rank correlation test for publication bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Meta-analysis, funnel plots and sensitivity analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and cancer risk: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Brick by brick: metabolism and tumor cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and risk of bladder cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and risk of breast cancer: a meta-analysis of observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Statin use and reduced cancer-related mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Impact of statin therapy on survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.04.007

10.1016/J.YGYNO.2014.04.007

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference